Zou H, Yin W, Geng P, Lin L, Nie X, Tao Z
Ann Hematol. 2024; 104(1):761-771.
PMID: 39402313
PMC: 11868322.
DOI: 10.1007/s00277-024-06028-9.
Shimojima M, Nishimura Y, Miyazawa T, Kato K, Nakamura K, Izumiya Y
Immunology. 2002; 105(3):360-6.
PMID: 11918698
PMC: 1782671.
DOI: 10.1046/j.0019-2805.2001.01371.x.
Lash G, Legge M
J Assist Reprod Genet. 1994; 11(6):320-2.
PMID: 7734919
DOI: 10.1007/BF02215721.
Van Wauwe J, Goossens J, DeCock W, Kung P, Goldstein G
Immunology. 1981; 44(4):865-71.
PMID: 6976312
PMC: 1554993.
Chanard J, Bach J, Assailly J, FUNCK-BRENTANO J
Br Med J. 1972; 2(5812):502-4.
PMID: 5064042
PMC: 1788334.
DOI: 10.1136/bmj.2.5812.502.
The use of complexes of lymphocyte antigens with antibody as immunogens for the preparation of antilymphocytic sera.
Zola H, Thomas D, Mosedale B
Experientia. 1972; 28(2):192-3.
PMID: 5020355
DOI: 10.1007/BF01935752.
Mechanism of complement action in rosette inhibition and lymphocytotoxicity of antilymphocyte serum.
Bach J, Gigli I, Dardenne M, Dormont J
Immunology. 1972; 22(4):625-35.
PMID: 5016236
PMC: 1407844.
The use of the indirect fluorescent antibody technique in assessing the activity of antilymphocytic sera and antilymphocytic globulins.
Thomas D, Mosedale B, Zola H
Clin Exp Immunol. 1971; 8(6):987-91.
PMID: 4997074
PMC: 1713031.
[Inhomogeneity of peripheral lymphocytes. Complement receptors in a portion of human lymphocytes].
Michlmayr G, Pastner D, HUBER H
Klin Wochenschr. 1970; 48(10):634-6.
PMID: 4996122
DOI: 10.1007/BF01485400.
Rosette formation by peripheral lymphocytes. II. Inhibition of the phenomenon.
Brain P, Gordon J
Clin Exp Immunol. 1971; 8(3):441-9.
PMID: 4995960
PMC: 1712918.
The production of antilymphocytic serum.
WOIWOD A
Proc R Soc Med. 1970; 63(9):949-50.
PMID: 4991013
PMC: 1812194.
Antigen recognition by T-cells and its suppression. Significance and origin of rosette-forming cells.
Bach J
Ann Rheum Dis. 1971; 30(6):565-73.
PMID: 4943204
PMC: 1005831.
DOI: 10.1136/ard.30.6.565.
Analysis of the biological activity of antilymphocyte serum. 3. Concentration of immunosuppressive activity in one IgG subfraction and its inhibition by another.
Perper R, Monovich R, Van Gorder T
Immunology. 1971; 21(6):883-902.
PMID: 4943146
PMC: 1408248.
Clinical evaluation of a rosette inhibition test in renal allotransplantation.
Munro A, Bewick M, MANUEL L, Cameron J, Ellis F, Boulton-Jones M
Br Med J. 1971; 3(5769):271-6.
PMID: 4934045
PMC: 1799099.
DOI: 10.1136/bmj.3.5769.271.
Antilymphocytic serum--the possible clinical applications.
Lessof M
Proc R Soc Med. 1970; 63(9):954-5.
PMID: 4920442
PMC: 1812129.
Rosette formation by peripheral blood lymphocytes in rheumatoid arthritis.
Keith H, Currey H
Ann Rheum Dis. 1973; 32(3):202-7.
PMID: 4736695
PMC: 1006079.
DOI: 10.1136/ard.32.3.202.
Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.
Whelan G, Sherlock S
Gut. 1972; 13(11):907-14.
PMID: 4674992
PMC: 1412408.
DOI: 10.1136/gut.13.11.907.
Antibody titres of antilymphocytic sera and globulins determined by immunofluorescence and their correlation with immunosuppressive activity.
Thomas D, Woodrooffe J, Mosedale B, Ward P, Zola H, EDWARDS D
Clin Exp Immunol. 1972; 11(4):569-78.
PMID: 4628577
PMC: 1553702.
Immunocytoadherence during experimental histoplasmosis.
Roberts G, LARSH H
Infect Immun. 1974; 10(1):30-3.
PMID: 4601766
PMC: 414952.
DOI: 10.1128/iai.10.1.30-33.1974.
Evaluation of rosette inhibition test in renal transplantation.
Wood R, Gray A
Br Med J. 1973; 4(5893):649-51.
PMID: 4586065
PMC: 1587687.
DOI: 10.1136/bmj.4.5893.649.
